View in EDS

Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Saved in:
Bibliographic Details
Title: Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.
Authors: Wermke M; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.; National Center for Tumor Diseases, Dresden, Germany., Araujo DM; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chatterjee M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany., Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Holderried TAW; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany., Jazaeri AA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reshef R; Columbia University Medical Center, New York, NY, USA., Bokemeyer C; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Alsdorf W; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Wetzko K; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany., Brossart P; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany., Aslan K; Immatics Biotechnologies GmbH, Tübingen, Germany., Backert L; Immatics Biotechnologies GmbH, Tübingen, Germany., Bunk S; Immatics Biotechnologies GmbH, Tübingen, Germany., Fritsche J; Immatics Biotechnologies GmbH, Tübingen, Germany., Gulde S; Immatics Biotechnologies GmbH, Tübingen, Germany., Hengler S; Immatics Biotechnologies GmbH, Tübingen, Germany., Hilf N; Immatics Biotechnologies GmbH, Tübingen, Germany., Hossain MB; Immatics US, Inc., Houston, TX, USA., Hukelmann J; Immatics Biotechnologies GmbH, Tübingen, Germany., Kalra M; Immatics US, Inc., Houston, TX, USA., Krishna D; Immatics US, Inc., Houston, TX, USA., Kursunel MA; Immatics Biotechnologies GmbH, Tübingen, Germany., Maurer D; Immatics Biotechnologies GmbH, Tübingen, Germany., Mayer-Mokler A; Immatics Biotechnologies GmbH, Tübingen, Germany., Mendrzyk R; Immatics Biotechnologies GmbH, Tübingen, Germany., Mohamed A; Immatics US, Inc., Houston, TX, USA., Pozo K; Immatics US, Inc., Houston, TX, USA., Satelli A; Immatics US, Inc., Houston, TX, USA., Letizia M; Immatics Biotechnologies GmbH, Tübingen, Germany., Schuster H; Immatics Biotechnologies GmbH, Tübingen, Germany., Schoor O; Immatics Biotechnologies GmbH, Tübingen, Germany., Wagner C; Immatics Biotechnologies GmbH, Tübingen, Germany., Rammensee HG; Institute of Immunology, Eberhard Karls University Tübingen, Tübingen, Germany., Reinhardt C; Immatics Biotechnologies GmbH, Tübingen, Germany., Singh-Jasuja H; Immatics Biotechnologies GmbH, Tübingen, Germany., Walter S; Immatics US, Inc., Houston, TX, USA., Weinschenk T; Immatics Biotechnologies GmbH, Tübingen, Germany., Luke JJ; Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Britten CM; Immatics Biotechnologies GmbH, Tübingen, Germany. cedrik.britten@immatics.com.
Source: Nature medicine [Nat Med] 2025 Jul; Vol. 31 (7), pp. 2453.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40301562
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Autologous T cell therapy for PRAME<superscript>+</superscript> advanced solid tumors in HLA-A*02<superscript>+</superscript> patients: a phase 1 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wermke+M%22">Wermke M</searchLink>; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.; National Center for Tumor Diseases, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Araujo+DM%22">Araujo DM</searchLink>; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chatterjee+M%22">Chatterjee M</searchLink>; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Tsimberidou+AM%22">Tsimberidou AM</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Holderried+TAW%22">Holderried TAW</searchLink>; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Jazaeri+AA%22">Jazaeri AA</searchLink>; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Reshef+R%22">Reshef R</searchLink>; Columbia University Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bokemeyer+C%22">Bokemeyer C</searchLink>; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Alsdorf+W%22">Alsdorf W</searchLink>; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Wetzko+K%22">Wetzko K</searchLink>; Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Brossart+P%22">Brossart P</searchLink>; Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Aslan+K%22">Aslan K</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Backert+L%22">Backert L</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bunk+S%22">Bunk S</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Fritsche+J%22">Fritsche J</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Gulde+S%22">Gulde S</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hengler+S%22">Hengler S</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hilf+N%22">Hilf N</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hossain+MB%22">Hossain MB</searchLink>; Immatics US, Inc., Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hukelmann+J%22">Hukelmann J</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kalra+M%22">Kalra M</searchLink>; Immatics US, Inc., Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Krishna+D%22">Krishna D</searchLink>; Immatics US, Inc., Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kursunel+MA%22">Kursunel MA</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Maurer+D%22">Maurer D</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Mayer-Mokler+A%22">Mayer-Mokler A</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Mendrzyk+R%22">Mendrzyk R</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Mohamed+A%22">Mohamed A</searchLink>; Immatics US, Inc., Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Pozo+K%22">Pozo K</searchLink>; Immatics US, Inc., Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Satelli+A%22">Satelli A</searchLink>; Immatics US, Inc., Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Letizia+M%22">Letizia M</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schuster+H%22">Schuster H</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schoor+O%22">Schoor O</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Wagner+C%22">Wagner C</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rammensee+HG%22">Rammensee HG</searchLink>; Institute of Immunology, Eberhard Karls University Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Reinhardt+C%22">Reinhardt C</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Singh-Jasuja+H%22">Singh-Jasuja H</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Walter+S%22">Walter S</searchLink>; Immatics US, Inc., Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Weinschenk+T%22">Weinschenk T</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Luke+JJ%22">Luke JJ</searchLink>; Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Britten+CM%22">Britten CM</searchLink>; Immatics Biotechnologies GmbH, Tübingen, Germany. cedrik.britten@immatics.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2025 Jul; Vol. 31 (7), pp. 2453.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40301562
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-025-03731-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2453
    Titles:
      – TitleFull: Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wermke M
      – PersonEntity:
          Name:
            NameFull: Araujo DM
      – PersonEntity:
          Name:
            NameFull: Chatterjee M
      – PersonEntity:
          Name:
            NameFull: Tsimberidou AM
      – PersonEntity:
          Name:
            NameFull: Holderried TAW
      – PersonEntity:
          Name:
            NameFull: Jazaeri AA
      – PersonEntity:
          Name:
            NameFull: Reshef R
      – PersonEntity:
          Name:
            NameFull: Bokemeyer C
      – PersonEntity:
          Name:
            NameFull: Alsdorf W
      – PersonEntity:
          Name:
            NameFull: Wetzko K
      – PersonEntity:
          Name:
            NameFull: Brossart P
      – PersonEntity:
          Name:
            NameFull: Aslan K
      – PersonEntity:
          Name:
            NameFull: Backert L
      – PersonEntity:
          Name:
            NameFull: Bunk S
      – PersonEntity:
          Name:
            NameFull: Fritsche J
      – PersonEntity:
          Name:
            NameFull: Gulde S
      – PersonEntity:
          Name:
            NameFull: Hengler S
      – PersonEntity:
          Name:
            NameFull: Hilf N
      – PersonEntity:
          Name:
            NameFull: Hossain MB
      – PersonEntity:
          Name:
            NameFull: Hukelmann J
      – PersonEntity:
          Name:
            NameFull: Kalra M
      – PersonEntity:
          Name:
            NameFull: Krishna D
      – PersonEntity:
          Name:
            NameFull: Kursunel MA
      – PersonEntity:
          Name:
            NameFull: Maurer D
      – PersonEntity:
          Name:
            NameFull: Mayer-Mokler A
      – PersonEntity:
          Name:
            NameFull: Mendrzyk R
      – PersonEntity:
          Name:
            NameFull: Mohamed A
      – PersonEntity:
          Name:
            NameFull: Pozo K
      – PersonEntity:
          Name:
            NameFull: Satelli A
      – PersonEntity:
          Name:
            NameFull: Letizia M
      – PersonEntity:
          Name:
            NameFull: Schuster H
      – PersonEntity:
          Name:
            NameFull: Schoor O
      – PersonEntity:
          Name:
            NameFull: Wagner C
      – PersonEntity:
          Name:
            NameFull: Rammensee HG
      – PersonEntity:
          Name:
            NameFull: Reinhardt C
      – PersonEntity:
          Name:
            NameFull: Singh-Jasuja H
      – PersonEntity:
          Name:
            NameFull: Walter S
      – PersonEntity:
          Name:
            NameFull: Weinschenk T
      – PersonEntity:
          Name:
            NameFull: Luke JJ
      – PersonEntity:
          Name:
            NameFull: Britten CM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1